Vaxcyte (PCVX) announced it has appointed Dr. Olivier Brandicourt, a veteran biopharmaceutical industry executive and the former Chief Executive Officer of Sanofi (SNY), to its Board of Directors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCVX:
- Vaxcyte initiated with an Overweight at Cantor Fitzgerald
- Biotech Alert: Searches spiking for these stocks today
- Vaxcyte’s Promising Prospects: Buy Rating Reinforced by Positive Phase 2 Data and Strategic Expansion
- Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
- BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue